Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase from Mycobacterium tuberculosis with Sulfonamides and a Sulfamate-Reference-Cited by-同舟云学术

Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase from Mycobacterium tuberculosis with Sulfonamides and a Sulfamate

Published:2009-03-24 Issue:8 Volume:52 Page:2226-2232
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Minakuchi Tomoko¹,Nishimori Isao¹,Vullo Daniela¹,Scozzafava Andrea¹,Supuran Claudiu T.¹

Affiliation:

1. Department of Gastroenterology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan, and Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Room 188, Via della Lastruccia 3, I-50019 Sesto Fiorentino (Firenze), Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9000488

Reference37 articles.

1. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

2. Emerging Drugs for Active Tuberculosis

3. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment

4. Recent advances in antituberculous drug development and novel drug targets

5. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism;Computers in Biology and Medicine;2024-10

2. Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies;Archiv der Pharmazie;2024-03-18

3. Sulfonamide inhibitors of bacterial carbonic anhydrases;The Enzymes;2024

4. Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies;The Enzymes;2024

5. Challenges for developing bacterial CA inhibitors as novel antibiotics;The Enzymes;2024